http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314070-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dfa86dfba2b4f45a868b0aa77831e23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e682c81188a9ff18316cd8c7f5af2064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63ce08637014eb68ff229ec4463666c9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2011-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a125df93f033bc116e547cdd083ff1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7f58b9abf88ac785046512bee1baea |
| publicationDate | 2012-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8314070-B2 |
| titleOfInvention | Osmoprotective complexes for prevention of intra-cellular dehydration in mammals |
| abstract | This invention relates to certain Aloesin derivatives with natural amino acids, peptides, and amino sugars (formula I). The compounds of the present invention possess osmoprotective properties, which are suitable for topical or oral application to treat dermatological disorders including challenged skin from cancer, diabetes, radiation treatments, chemotherapy, and sun-burn; mitochondrial dysfunction, age spots, acne, loss of cellular antioxidants, collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles including fine lines, oxidation, damage from radiation, damage from free radicals, damage from UV, dry skin, xerosis, ichthyosis, dandruff, brownish spots, keratoses, melasma, lentigines, liver spots, pigmented spots, dark circles under the eyes, skin pigmentation including darkened skin, blemishes, oily skin, warts, eczema, pruritic skin, psoriasis, inflammatory dermatoses, topical inflammation, disturbed keratinization, skin changes associated with aging, scalp dryness, skin depigmentation, intracellular dehydration, and combinations thereof: |
| priorityDate | 2006-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3482.